About

As tech giants such as Google, Amazon, Apple and others continue to invest in healthcare, IMNA Solutions is a startup to watch. IMNA Solutions is an Israel-based software company with offices in Arizona, focused on improving quality of healthcare and reducing administrative costs as much as 60% by turning unstructured data into real-time actionable insights.  The company has created IMNA Health, a patented, highly secured data collection and patient management platform that is disorder agnostic. IMNA Health uses predictive analytics and artificial intelligence to collect and extract patient healthcare information from multiple sources. The platform was designed to improve personalized health care, patient-reported outcomes and clinical decision support.

With a team comprised of renowned doctors, medical professionals, security specialists and data scientists, IMNA Solutions is pioneering the future of healthcare. IMNA Solutions’ software is HIPPA and GDPR compliant with military-grade encryption, ensuring that patient data can’t be compromised.

After opening its first U.S. office in Maryland, IMNA Solutions decided to establish its U.S. headquarters in Scottsdale. Since locating in Arizona, IMNA Solutions has been better able to respond to its market’s growing needs. Healthcare is the fastest growing industry in Arizona and is home to some of the top innovations in medical research, diagnostics and treatment. The state’s business-friendly climate and support from local organizations like the Arizona Israel Technology Alliance, Arizona Commerce Authority and Arizona Technology Council have also furthered IMNA Solutions’ entry into the market. IMNA Solutions is also a proud member of Perimeter83, a one-of-a-kind corporate training and technology startup coworking space nestled on the UAT campus in Tempe, Arizona.

The IMNA Health platform is also revolutionizing the clinical trial industry by improving communication with patients and reducing patient dropout rates. According to Forte Research, a staggering 85% of clinical trials fail to retain enough patients, due lack of appreciation, misunderstood expectations, scheduling conflicts and forgetting visits—all of which are preventable with better communication. CB Insights reports that over 50% of clinical trials are rejected by the FDA due to incorrect or incomplete reported data. IMNA Health is able to improve communication by monitoring patients through their entire clinical trial journey, allowing them to update pharmacists and researchers with their feelings, concerns and symptoms in real-time. This is key, as high patient dropout rates prevent researchers from garnering sufficient patient data, which in turn prevents the FDA from approving potentially life-saving drugs.